The importance of cytochrome P450 isoforms to species diferences in the metabolism of foreign compounds and activation of procarcinogens has been identified. humans. This paper focuses on examples in which species differences in P450s lead to significant alterations in cogenic response, and indudes a discussion of the current procedures for toxicity screening, with an emphasis on short-term tests.
hap;lleJ1psp ..niebs.nih.gwvdo,csll99/10S6p633-641-kaistrachtmIl There is much current concern (1-6) over the suitability of animal species as surrogates for Homo sapiens in chemical safety evaluation; one reason for this stems from the finding that, compared to the fairly large number (>400) of known rodent carcinogens (7) (8) (9) (10) (11) , only a relatively small number of compounds (-20-30) have been shown to be carcinogenic in humans (12, 13) . This has led to the view that small mammalian species-such as those used experimentally in, for example, the rodent bioassay-are more susceptible to carcinogenicity than are human populations. Although the reasons for this disparity may be due to the fact that rodent carcinogenicity test procedures involve life-span studies with the chemical administered at its maximum tolerated dose (MTD), whereas human exposure is not normally under controlled conditions, the variation in body size could represent one factor in differential tumor susceptibility, as has been shown for diethylnitrosamine in various animal species (14) . Furthermore, there are many examples of marked species differences (15) in the toxicity of foreign compounds, with one particular animal model representing a doser paradigm to Homo sapiens than another depending on the chemical concerned. Although there may be many reasons for these differences, it is likely that some may be traced to variations in primary metabolism between species in which the cytochrome P450 (CYP) mono-oxygenases are mainly involved (16) (17) (18) (19) .
Xenobiotic metabolism is generally regarded as proceeding via two stages, Phase I and Phase II; the initial oxidative stage in Phase I is followed by conjugation by a second dass of enzyme, usually referred to as a conjugase. Over 90% of Phase I metabolism is mediated by cytochromes P450, a superfamily of heme-thiolate enzymes of which over 750 individual members have now been characterized in terms of gene or protein sequence data (20) (21) (22) (23) ; only 36 human P450s have been sequenced to date, whereas in the rat, 47 P450s are known from isolated cDNAs, etc. In mammals, exogenous metabolism occurs mainly in the liver, which also represents the major site of P450 proteins, although smaller concentrations are found in other organs and tissues. Apart from those isoforms primarily associated with endobiotic metabolism, hepatic microsomal P450s comprise members of families CYP1, CYP2, and CYP3, of which the CYP2 family possesses five main subfamilies, CYP2A through to CYP2E. The CYPI family contains two major isozymes, CYPlA1 and CYP1A2, which appear to be highly conserved across most animal species in terms of primary sequence homology, as is the CYP2E subfamily (19, 22, 24) . The major xenobiotic-metabolizing P450 isoforms in five mammalian species are shown in Table 1 .
It is generally recognized that induction of P450s associated with metabolic activation (e.g., CYPIA and CYP2E) is also regarded as indicative of potential toxicity/carcinogenicity (25) (26) (27) . However, CYPlAI, an isoform most dosely associated with the activation of procarcinogens [such as benzo(a)pyrene] in small rodents and readily inducible by polycyclic aromatic hydrocarbons (PAHs) and 2,3,7,8-tetra- chlorodibenzo-p-dioxin (TCDD) , is poorly expressed in human liver (28) and, consequently, is not likely to be of relevance to human hepatocarcinogenicity. Nevertheless, CYPlAI is expressed in human lung (28) and also has been shown to be readily induced by procarcinogenic PAHs, induding those present in cigarette smoke and exhaust emissions, thus constituting a potentially important factor in pulmonary carcinoma. CYP1A2, however, is involved in the metabolic activation of polyaromatic and heterocyclic amines and amides, such as those formed during the cooking of meat products; this form is both present and inducible in human liver (28) as well as in liver of experimental animals species. Consequently, although CYPIA and CYP2E subfamilies are well conserved across mammalian species, variations in their expression/induction and its consequences [reviewed by Lewis (23) ] can explain some of the examples of species differences in the metabolism and activation of potentially toxic chemicals such as butadiene (29) . CYP2E, for example, is inducible by low molecular weight compounds such as benzene, ethanol, acetone, carbon tetrachloride, and dichloromethane; it appears that many of the toxic consequences of CYP2E induction are due to the associated generation of reactive oxygen species (ROS) (27, 30) . There is evidence to suggest that small rodents such as the mouse (31) are more susceptible to the toxic/carcinogenic effects of ROS production often associated with CYP2E induction (32) . Although there is some relationship between ROS-mediated toxicity and body weight (33) in which species life span could also be a factor (34) , the increased susceptibility of small rodents to ROS relative to the situation in Homo sapiens may be due to the fact that glutathione their cellular GSH on exposure to ROS-generating chemicals (35) but not in humans, Table 1. P450 isoforms in various mammalian speciesa  CYP  Human  Monkey  Rabbit  Rat  Mouse  1A   1A1, 1A2  1Al, 1A2  1A1, 1A2  1A1, 1A2  1A1, 1A2   2B  2B6  2B17  2B4,22B5  2B1,2B2,22B3  2B9, 2B10, 2B13   20  206  2D17  2D1,2D2,2D3,  2D9,2D10,2D11,  2D4, benzo(a)pyrene; PAHs, polyaromatic hydrocarbons; PhIP, 2-amino-1-methyl-6-phenylimidazo-(4,5-b)pyridine; Glu-P-1, 2-amino-6-methyl-dipyrido(1,2-a.3,2'-dfimidazole; Glu-P-2, 2-aminodipyrido(1,2-ar.3,2'-d)imidazole; IQ 2-amino-3-methylimidazo(4,5-t4quinoline; MelQ, 2-amino-3,5-dimethylimidazo(4,5-4quinoline; MelQx, 2-amino-3,5-dimethylimidazo(4,5-tquinoxaline; Trp-P-2, 3-amino-1-methyl-5H-pyrido(4,3-b)indole; 2-AAF, 2-acetylaminofluorene; NNK, 4-(methyinitrosamino)- (19, 36) as shown in Table 2 , whereas others are largely associated with detoxifying metabolism (21, 37) . Moreover, it is possible to trace species differences in xenobiotic metabolism to variations in P450 levels, their inducibiities, and the existence of different P450 isoforms of the same protein family or subfamily in various mammalian species (19, 23 (42) .
In addition to these differences in the P450s themselves, the levels of the various isoforms differ markedly between species and are also subject to different regulatory mechanisms. Furthermore, experimental animals are maintained in a strictly controlled environment under specific dose regimens and dietary restrictions (43) (44) (45) , which is in complete contrast to the situation experienced by the majority of humans. As The main reason for these species differences in carcinogenicity probably involves the relevant P450 isozymes that metabolize the compounds concerned. For coumarin, the major route of metabolism in humans, i.e., the 7-hydroxylation, is catalyzed by P4502A6 (CYP2A6), whereas the analogous mouse ortholog is CYP2A5, which mediates the same metabolic pathway. However, in the rat, the CYP2A1 isoform facilitates formation of the carcinogenic 3,4-epoxide, and this signiflcant species variation can be explained by molecular modeling of the relevant enzymes' active sites (55) . Similarly, the species differences in butadiene metabolism can be rationalized by active site modeling of the CYP2E1 enzymes from rats, mice, and humans (55) . (63) , correlations were less than 40% between mutagenic potency (revertants per mM/l/plate) and carcinogenic potency (increased tumor risk per mM/kg/day). However, these correlations could be improved to just over 60% when fewer chemicals were considered (63) .
Nevertheless, the low cost and straightforwardness of the Ames test has led to its general adoption as a standard technique for assessing the potential genotoxicity of chemicals destined for human exposure. Indeed it is useful and informative to establish whether the carcinogenicity of a compound is made manifest via a genotoxic mechanism, either by directly reacting with DNA (48, 64, 65) or as a result of enzymic activation; the comparison between Ames tests conducted with or without S9 will facilitate this, and if both are negative, the chemical concerned can then be regarded as a nongenotoxic carcinogen. The ways in which carcinogenicity may be in evidence without genotoxicity include receptormediated events such as those produced by peroxisome proliferators, by estrogenic compounds, and by chemicals such as TCDD, which are potent inducers of cytochrome P4501 (CYPI) via high-affinity binding to the cytosolic aryl hydrocarbon (Ah) receptor (26) . In fact, the estrogen receptor and peroxisome proliferatoractivated receptor are both members of the steroid hormone receptor superfamily and are involved in promoting cell growth, whereas the Ah receptor is another type of nuclear receptor, which is also associated with increased cell division following translocation to the nucleus of its ligandbound complex. All of these receptors, however, bind to specific DNA response elements in the regulatory (noncoding) regions of particular genes associated with the production of enzymes and other proteins involved in cell proliferation (23, 38) .
ENACT (enzyme activation in chemical toxicity), a short-term procedure related to the modified Ames test (i.e., involving an activation system), is associated with P450 enzyme induction (27) ; in contrast to the in vitro Ames test, ENACT uses a small number of animals to assess the ability of a chemical to raise the levels of some key P450 isozymes that have been associated with toxic effects. By measuring the extent of induction at differing dose levels, it is possible to establish whether the particular increase in the P450 concerned is dose dependent, such that dose-response relationships can be formulated. This is useful for establishing the inducing ability of the chemical, thus providing a possible estimate of threshold exposure levels in humans.
There is satisfactory agreement between the Ames test (with S9 mix) and enzyme induction studies in some cases (25, 26) , whereas either or both of these procedures are sometimes in line with carcinogenicity data for certain chemicals. There are also examples where the results of these techniques can be explained in terms of the molecular or electronic structures of the compounds themselves (66) . Furthermore, both the Ames and ENACT tests produce numerical values that allow the data to be analyzed via quantitative structure-activity relationship (QSAR) studies, whereby correlations are sought between biological activity and one or more descriptor variables that may come from either a physicochemical measurement or a computerassisted evaluation of the chemicals' molecular and/or electronic structures (67) (68) (69) (70) (71) (72) (73) (74) (75) . Such QSAR procedures, which also involve the use of statistical methods for assessing correlations between what may be a relatively large number of parametric variables, can be extremely helpful in both formulating a rational description of potency differences within series of related chemicals and in providing a means for predicting the likely activity/toxicity of untested compounds (68, 69, 76) . There are several descriptor variables often found to be involved in the explanation of differences in toxicity and other forms of biological activity for many classes of chemicals (68): octanol-water partition coefficient (log P.,); water solubiity; acid-base dissociation constant (pKa); molecular weight; vapor pressure; molar refractivity; molar polarizability; superdelocalizability; molecular orbital energies (HOMO, highest occupied molecular orbital; LUMO, lowest unoccupied molecular orbital); dipole moment; molecular electrostatic potential/electrostatic isopotential (MEP/EIP); and electron densities/atomic charges. As far as the oil/water partition coefficient (and the related octanol-water partition coefficient; Poct) is concerned, there are numerous examples of the use of this estimate of compound lipophiicity being correlated with changes in biological potency for large numbers of structurally related series of chemicals (77, 78 
Computer-based Tests
Use of computers has made a huge impact on virtually all aspects of modern living. However, the employment of computer technology in toxicity screening has always been a controversial subject for various reasons (79) , including a considerable suspicion of computer-generated data by many toxicologists and the difficulty of directly relating molecular structural parameters to a biological end point, which can often involve several sequential stages and may be susceptible to a variety of largely external factors such as environment, diet, and dose regimen, for example.
The attraction of using computers in toxicity testing is obvious to most scientists involved in the safety evaluation of chemicals destined for human exposure and for hazard identification of substances in the environment. There are several advantages of computer-based procedures: they are rapid, relatively inexpensive, and always reproducible, and they allow researchers to avoid the need for actual chemical synthesis and any form of experimentation (80) . However, care needs to be exercised in interpretating computer-generated results; for example, the outcome of QSAR analyses can, under certain circumstances, be misleading in terms of overinterpretation of inadequate or insufficient data. Nevertheless, as a tool used with other noninvasive in vitro procedures, some computer methods (see Table 4 ) for toxicity testing can be extremely helpful in prescreening chemicals and for prioritization of large numbers of compounds for further evaluation using short-term procedures (81) . Moreover, there have been many examples which demonstrate that computer-based evaluations can explain the findings of biological studies, including the rodent carcinogenicity bioassay; in some cases, these are able to provide a satisfactory level of prediction, which can be as high as about 70%. Indeed, the employment of a battery of computer tests and other shortterm procedures could prove extremely useful as an alternative to the life-span rodent bioassay. Many groups of investigators worldwide are currently involved in developing a variety of computer methods for the prediction of carcinogenicity (69, 81) .
Species Differences Relating to P450 Variations
A potential difficulty emerges, however, when one has to consider the possible effects of species differences in metabolism and toxic response of chemicals. Extrapolation of experimental data from small rodents and other mammalian test species to Homo sapiens is not always straightforward, although there can be an approximately linear relationship between activity and species body weight; more frequently, such relationships tend to be nonlinear but may, nevertheless, be amenable to statistical analysis. Nonlinear relationships between, for example, Phase 1 metabolism and species body weight are often due to orthologous P450s in those species, differential distribution of the P450 isoforms responsible for bioactivation, and/or a variation in mechanism that may involve different P450 families or subfamilies. Such considerations can be addressed, albeit partially, by molecular modeling of the P450 isozymes involved in chemical metabolism, but such procedures are in the early stages of development (23) . However, the metabolism of tamoxifen in Homo sapiens, for example, can be explained by modeling the interaction of this substrate within the active sites of the P450s involved, thus demonstrating the potential for a technique that can predict the likely metabolic fate of an untested chemical even before synthesis. The success of procedures such as these for exploring all metabolic and toxic possibilities for a new compound, which may be intended for use as a therapeutic agent, requires the detailed structural analysis of every enzyme or protein that could be involved in metabolism or toxic activation; this necessitates carrying out crystallographic and/or nudear magnetic resonance (NMR) studies on at least one protein in each class such that a reasonable homology model can be constructed. Benigni and coworkers (82, 83) have stressed that the importance of (92) has some advantages over DEREK, as it calculates log P and pKa, it runs on a PC, and is available to academics at a considerably reduced cost. TOPKAT (93) performs well for certain classes of chemicals within its database, but is expensive for academics because there is no educational discount offered.
the biological activity data is often overlooked in QSAR studies because scientific scrutiny tends to become focused on the structural descriptors and their statistical significance. The normally wide variation and margins of error in the biological data are usually disregarded in the search for apparendy highly significant correlations.
For drug metabolism via P450 isozymes, the following examples serve to illustrate the importance of considering the metabolic pathways and enzymes involved. First, the metabolism of hexobarbital has been studied in various mammalian species, and the results are shown in Table 5 . In this case, the half-life ofthe drug (t112) exhibits a good correlation (r = 0.83) with body weight (W) for the five species, provided that the raw data are converted into their logarithmic form. The relationship (shown in Fig. 1 ) then becomes as follows: log tl/2 = 0.323 (± 0.127) log W + 1.994, where n = 5; standard error (SE) = 0.336; r= 0.8256; F(variance ratio) = 6.42.
Hexobarbital is metabolized by P450s of the CYP2B and CYP2C subfamilies in the rat and humans, so it may be reasonable to assume that these are also involved the mouse, rabbit, and dog, in which barbiturates tend to exhibit induction of both subfamilies, with a preference for CYP2B (84) . Although CYP2B isozymes are inducible in both rodents and in rabbits, this is not the case in Homo sapiens; in humans, the level of the CYP2B6 ortholog is extremely low in hepatic tissue (85) and (94. is apparently poorly induced by phenobarbital and other barbiturate drugs, which is in complete contrast with the situation in rats, mice, and rabbits (84) . Such considerations may explain the relatively long halflife in humans where the CYP2C subfamily of isozymes, particularly CYP2C19, appear to be the major catalysts of hexobarbital metabolism (86) .
Second, omeprazole metabolism has been studied in several mammalian species, and the clearance data are presented in Table  6 . In Homo sapiens, the major route of metabolism appears to be a methyl hydroxylation step, which is primarily catalyzed by CYP2C19, a known polymorphic isoform; however, CYP3A4 is also involved in omeprazole metabolism, and being the main component of human liver P450, this pathway represents an important secondary route ofomeprazole dearance in humans (87) .
There is significant variation in the complement of P450 isoforms between Homo sapiens and other mammalian species. For example, CYP2B is well conserved between rodents and rabbits, but is poorly expressed in human liver. In contrast, CYP3A represents the major component of human hepatic P450 although the levels of this subfamily are generally quite low in other species, especially in experimental animals. The CYP2C subfamily in humans possesses distinctly different isoforms that exhibit varying substrate specificity, and human CYP2C19 is subject to genetic polymorphism. Consequently, although hexobarbital is likely to be metabolized in the same position in most mammalian species via CYP2B and/or CYP2C subfamily mediation, the metabolism of omeprazole and tamoxifen, for example, is more complex, with several Phase 1 pathways being mediated by different P450s. The data presented in Tables 5 and 6 indicate that there is a general relationship between rate of metabolism and body weight, but because of the different P450s involved and their altered levels between species, the relevant metabolic rate changes from animals to humans depend on the nature ofthe chemical being metabolized.
For omeprazole intrinsic dearance (CLm,t) in the four mammalan species, a log-log relationship with body weight also holds, but the best fit with the data is given by the following =int = 4.077 (± 0 
Conclusions
Consequently, the extrapolation of animal data to humans is not always simple and straightforward due to species differences in the P450 enzymes present, including their active site differences, which may even occur within enzymes of the same family or subfamily. A review by Smith (16) provides further examples of such species differences in metabolism that can also be explained in terms of P450s and describes many important aspects of pharmacokinetics. In particular, the relevance of log D7.4 (D is the distribution coefficient) values were shown to be potentially useful for differentiating between substrates of different P450 isozymes, primarily CYP3A, CYP2C, and CYP2D isoforms, as these constitute the P450 enzymes in human liver that metabolize the large majority of currently used pharmaceuticals, although log D is also of importance in the context of Phase II metabolism.
The log D74 parameter is, in fact, the lipophiicity (log P) of a chemical that is ionization-corrected for a pH medium of 7.4, as this represents the most commonly used value for physiological pH. The expressions relating these quantities for compounds that are ionizable can be represented in the following way: log D7.4 = log P -log (1 + 1074-PKa) for acids log D74 = log P -log (1 + 10PKa-7.4) for bases Consequendy, it is relatively straightforward to evaluate the log D74 for any compound from the neutral log P value and pKa, provided that such information is available. It is important to use log D7.4 instead oflog P for the estimation of compound lipophilicity because ionization will diminish the observed lipophiic character of a chemical, provided that the compound contains groupings that may become partially ionized at physiological pH. Because log P is one of the major physicochemical parameters used in the safety evaluation of chemicals destined for human exposure, the potential for ionization is extremely relevant, particularly where P450-mediated metabolism is possible; this can provide an early indication of probable P450 isoform specificity. Furthermore, lipophilicity of a chemical plays an important role in its biological fate in almost all species, induding Homo sapiens, because this factor determines the bioavailability and bioaccumulation effects of the compound itself, and biological half-lives are often dosely related to lipophilic potential (88) . Therefore, from a compilation of short-term test data, physiochemical parameters, and molecular structural information, it should be possible to assess the likely risk to human health from exposure to a given substance; such procedures are currently under development in this laboratory and elsewhere. Figures 3 and 4 represent examples of how a decision tree approach may be applied tO both chemical safety evaluation and P450 specificity, respectively.
The decision tree approach to toxicity screening presented in Figure 3 has been constructed on the basis of several studies on predicting rodent carcinogenicity as conducted in this laboratory. We have proposed that this may also be of benefit in human risk assessment (89) . Figure 4 represents a decision tree for determining the likely P450 isoform speciflcity of a given chemical; this is based on extensive studies on the structural characteristics of substantial numbers of P450 substrates and inducers (90) . Although there are differences in the levels of P450 families and subfamilies, including tissue distribution, between humans and other animal species, the decision tree in Figure 4 can be employed across mammalian species because the particular P450 substrate specificities tend to remain relatively well-conserved when one compares specificities for individual P450 families and subfamilies. We hope that workers in the field will find these decision trees ot use in the screening of chemicals for potential toxicity, where possible species differences in metabolism may be attributable in part to the relative activities oforthologous P450 isoforms. 
